Abstraction
Cancer treatment has evolved and improved over time. Within the past few years, many new options have become available for patients that were just a dream no more than a decade ago. Some of the new methods on the forefront of cancer treatment Read more [...]
Newer genome editing technologies, such as CRISPR-Cas, are revolutionising scientific research and bringing about a myriad of potential applications in many fields. For science and technology to progress timely and efficiently, the societal debate must move forward at the same pace to help guide the direction of scientific research and to frame policy-making decisions. As this technology progresses, what will be the key questions to address as the public is engaged in these conversations? This article hints at some of them while a comprehensive list will be discussed at ESOF dilemma café session on Friday 13th –participate to find out! Read more [...]
Finding reliable funding in the course of a scientific career is difficult, even for the best scientists, says Emmanuelle Charpentier, head of regulation and infection biology at the Max-Planck-Institut in Berlin, Germany. Better known for her work on developing the CRISPR/Cas9 gene editing technique, she calls for an informed debate on the implications of her work and wishes to avoid giving into the media buzz without more in-depth reflection. In this first of a two-part series, Charpentiers shares her perspective in an authentic way. Read more [...]
In the second instalment of a two-part series, Emmanuelle Charpentier, head of regulation and infection biology at the Max-Planck-Institut in Berlin, Germany, gives her opinion on the challenges in obtaining research funding in the current system in Europe. She also shares her views on how mobility can be hampered by bureaucracy. Finally, she points to the limited coherence for scientists pursuing a research career in Europe. Clearly, many efforts have yet to be made to improve the condition of scientists in Europe. Read more [...]
In this interview, Sheila Jasanoff, expert of the 'science of looking at science' from Harvard Kennedy School, warns that regulatory bodies alone cannot take decisions on thorny contemporary scientific issues, such as how to regulate the CRISPR gene editing technology, without involving society at large. She explains how the first order of framing research with society's input is crucial for the future of science before even framing the problems to solve in scientific terms. This approach also implies putting oneself in the shoes of the people objecting to the results of scientific research. Read more [...]
European science conversations by the community, for the community
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
EuroScientist journal 